Development and validation of an echocardiographic algorithm to predict long-term mitral and tricuspid regurgitation progression

• Published in: European heart journal cardiovascular imaging 2022-11, Vol.23 (12), p.1606-1616
• Main Authors: Strom, Jordan B, Zhao, Yuansong, Shen, Changyu, Wasfy, Jason H, Xu, Jiaman, Yucel, Evin, Tanguturi, Varsha, Hyland, Patrick M, Markson, Lawrence J, Kazi, Dhruv S, Cui, Jinghan, Hung, Judy, Yeh, Robert W, Manning, Warren J
• Format: Article
• Language: English
• Subjects: Algorithms; Echocardiography; Humans; Mitral Valve Insufficiency - epidemiology; Original Paper; Retrospective Studies; Treatment Outcome; Tricuspid Valve Insufficiency - epidemiology
• ISSN: 2047-2404; 2047-2412; 2047-2412
• DOI: 10.1093/ehjci/jeab254

Prediction of mitral (MR) and tricuspid (TR) regurgitation progression on transthoracic echocardiography (TTE) is needed to personalize valvular surveillance intervals and prognostication. Structured TTE report data at Beth Israel Deaconess Medical Center, 26 January 2000-31 December 2017, were used to determine time to progression (≥1+ increase in severity). TTE predictors of progression were used to create a progression score, externally validated at Massachusetts General Hospital, 1 January 2002-31 December 2019. In the derivation sample (MR, N = 34 933; TR, N = 27 526), only 5379 (15.4%) individuals with MR and 3630 (13.2%) with TR had progression during a median interquartile range) 9.0 (4.1-13.4) years of follow-up. Despite wide inter-individual variability in progression rates, a score based solely on demographics and TTE variables identified individuals with a five- to six-fold higher rate of MR/TR progression over 10 years (high- vs. low-score tertile, rate of progression; MR 20.1% vs. 3.3%; TR 21.2% vs. 4.4%). Compared to those in the lowest score tertile, those in the highest tertile of progression had a four-fold increased risk of mortality. On external validation, the score demonstrated similar performance to other algorithms commonly in use. Four-fifths of individuals had no progression of MR or TR over two decades. Despite wide interindividual variability in progression rates, a score, based solely on TTE parameters, identified individuals with a five- to six-fold higher rate of MR/TR progression. Compared to the lowest tertile, individuals in the highest score tertile had a four-fold increased risk of mortality. Prediction of long-term MR/TR progression is not only feasible but prognostically important.